Tarsus Pharmaceuticals, Inc. — Investor Relations & Filings
Tarsus Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates for diseases with limited treatment options. The company's initial focus is on eye care. Its lead product, XDEMVY® (lotilaner ophthalmic solution) 0.25%, is the first and only FDA-approved treatment for Demodex blepharitis. Tarsus is also advancing a pipeline of potential treatments for other conditions with high unmet needs, including ocular rosacea, Lyme disease prevention, and other indications across dermatology and infectious diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Tarsus Pharmaceuticals, Inc. (0001819790) (Filer) | 2026-05-06 | English | |
| 144 - Tarsus Pharmaceuticals, Inc. (0001819790) (Subject) | 2026-03-20 | English | |
| 4 - Tarsus Pharmaceuticals, Inc. (0001819790) (Issuer) | 2026-03-20 | English | |
| 4 - Tarsus Pharmaceuticals, Inc. (0001819790) (Issuer) | 2026-03-20 | English | |
| 4 - Tarsus Pharmaceuticals, Inc. (0001819790) (Issuer) | 2026-03-20 | English | |
| 4 - Tarsus Pharmaceuticals, Inc. (0001819790) (Issuer) | 2026-03-20 | English |
Browse filings by year
7 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
JEIL PHARMA HOLDINGS INC.
Develops, manufactures, and distributes pharmaceuticals, AP…
|
002620 | KR | Manufacturing |
|
Jenburkt Pharmaceuticals Ltd.
Develops and manufactures healthcare formulations for vario…
|
524731 | IN | Manufacturing |
|
JETEMA Co.,Ltd.
Develops and manufactures toxins, fillers, and threads for …
|
216080 | KR | Manufacturing |
|
Jfl Life Sciences Limited
Manufactures and markets diverse pharmaceutical formulation…
|
JFLLIFE | IN | Manufacturing |
|
JIANERKANG MEDICAL CO., LTD.
Manufacturer of medical consumables, surgical dressings, an…
|
603205 | CN | Manufacturing |
|
JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD.
Biopharmaceutical firm developing innovative anti-HIV and a…
|
688488 | CN | Manufacturing |
|
Jiangsu Bioperfectus Technologies Co., Ltd.
Develops molecular diagnostic solutions and systems for inf…
|
688399 | CN | Manufacturing |
|
JIANGSU COWIN BIOTECH CO., LTD.
Develops molecular biology reagents and kits for research a…
|
688426 | CN | Manufacturing |
|
Jiangsu Jibeier Pharmaceutical Co.,Ltd.
Develops innovative chemical and biological drugs for ophth…
|
688566 | CN | Manufacturing |
|
Jiangsu Kanion Pharmaceutical Co.,Ltd.
Develops and manufactures modern Traditional Chinese Medici…
|
600557 | CN | Manufacturing |
Tarsus Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31511/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31511 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31511 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31511 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31511}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Tarsus Pharmaceuticals, Inc. (id: 31511)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.